Clinical trial
Evaluation of Fapi-pet in Prostate Cancer
NCT05192694 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Fapi-pet in Prostate Cancer
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 10, 2022
- Completion date
- December 15, 2022
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer